{{scheme.chgp}}%
{{scheme.chgp}}%
No Matches Found
{{scheme.chgp}}%
No Matches Found
No Matches Found
Kothari Fermentation & Biochem Ltd
Kothari Fermentation & Biochem Ltd Falls to 52-Week Low Amidst Continued Downtrend
Kothari Fermentation & Biochem Ltd has declined to a fresh 52-week low of Rs.39, marking a significant downturn in its share price amid broader market gains. The stock’s recent performance contrasts sharply with the overall positive trend in the FMCG sector and the broader Sensex index.
Kothari Fermentation & Biochem Ltd: Valuation Shifts Signal Changing Price Attractiveness
Kothari Fermentation & Biochem Ltd, a player in the FMCG sector, has experienced a notable shift in its valuation parameters, moving from an attractive to a fair valuation grade. This change, coupled with its negative price-to-earnings ratio and subdued return metrics, raises important questions about its price attractiveness relative to peers and historical benchmarks.
Kothari Fermentation & Biochem Ltd is Rated Strong Sell
Kothari Fermentation & Biochem Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 14 July 2025, reflecting a reassessment of the stock’s outlook. However, the analysis and financial metrics discussed here represent the company’s current position as of 30 January 2026, providing investors with the latest insights into its performance and prospects.
Why is Kothari Fermentation & Biochem Ltd falling/rising?
As of 19-Jan, Kothari Fermentation & Biochem Ltd’s stock price has continued its downward trajectory, reflecting sustained underperformance relative to key benchmarks and technical indicators.
Kothari Fermentation & Biochem Ltd is Rated Strong Sell
Kothari Fermentation & Biochem Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 14 July 2025, but the analysis below reflects the stock’s current position as of 19 January 2026, incorporating the latest fundamentals, returns, and financial metrics.
Kothari Fermentation & Biochem Ltd is Rated Strong Sell
Kothari Fermentation & Biochem Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 14 July 2025, reflecting a reassessment of the company’s outlook. However, the analysis and financial metrics discussed below are based on the stock’s current position as of 07 January 2026, providing investors with the latest insights into its performance and prospects.
Kothari Fermentation & Biochem Ltd is Rated Strong Sell
Kothari Fermentation & Biochem Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 14 July 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 25 December 2025, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance.
Kothari Ferment. Sees Revision in Market Evaluation Amidst Challenging Financials
Kothari Ferment., a microcap player in the FMCG sector, has experienced a revision in its market evaluation reflecting ongoing challenges in its financial and operational performance. Recent assessment changes highlight concerns across multiple analytical parameters, signalling a cautious outlook for investors.
Is Kothari Ferment. overvalued or undervalued?
As of December 2, 2025, Kothari Ferment. is considered overvalued with a PE ratio of -24.53 and an EV to EBITDA of 12.35, showing poor performance with a 43.93% decline in stock price compared to the Sensex's 6.09% increase, despite having a lower PE ratio than peers like Hindustan Unilever and Nestle India.
Why is Kothari Ferment. falling/rising?
As of 18-Nov, Kothari Fermentation & Biochem Ltd's stock price is Rs 46.05, down 3.84%, and has underperformed its sector. The stock has declined 4.95% over the last three days and 38.60% year-to-date, contrasting sharply with the Sensex's 8.36% increase.
Is Kothari Ferment. overvalued or undervalued?
As of November 17, 2025, Kothari Ferment. is considered overvalued with a PE ratio of -26.22, high EV to EBITDA of 12.88, low ROCE of 2.23%, and negative ROE of -5.24%, significantly underperforming compared to peers and the Sensex.
Kothari Fermentation Q2 FY26: Losses Deepen Amid Margin Collapse
Kothari Fermentation and Biochem Ltd., a micro-cap yeast manufacturer with a market capitalisation of ₹72.00 crores, reported deeply concerning results for Q2 FY26, posting a net loss of ₹3.08 crores compared to a loss of ₹1.75 crores in the same quarter last year. The deterioration represents a staggering 773.80% decline versus the previous four-quarter average, marking the company's worst quarterly performance in recent years. The stock, currently trading at ₹47.90, has plummeted 47.30% over the past year, significantly underperforming both the Sensex and the FMCG sector.
How has been the historical performance of Kothari Ferment.?
Kothari Ferment's historical performance shows a recovery in Mar'25, with net sales rising to 114.23 Cr and operating profit improving to 11.87 Cr, compared to previous losses. Total assets and liabilities decreased, while cash flow from operations increased to 10.00 Cr.
Is Kothari Ferment. overvalued or undervalued?
As of November 7, 2025, Kothari Ferment. is considered very attractive due to its significant undervaluation with a PE ratio of -52.17, an EV to EBITDA of 11.09, and a low PEG ratio of 0.00, despite a year-to-date stock performance lagging at -34.61% compared to the Sensex's 6.50%.
Is Kothari Ferment. overvalued or undervalued?
As of November 7, 2025, Kothari Ferment. is considered very attractive and undervalued compared to peers, with a PE ratio of -52.17, an EV to EBITDA of 11.09, and a Price to Book Value of 1.30, despite a -49.88% return over the past year, suggesting potential for recovery in the FMCG sector.
Is Kothari Ferment. overvalued or undervalued?
As of November 7, 2025, Kothari Ferment. is considered very attractive due to its undervalued status, highlighted by a negative PE ratio of -52.17 and a PEG ratio of 0.00, making it a compelling investment opportunity compared to its peers like Hindustan Unilever and Nestle India, which have much higher valuations.
Is Kothari Ferment. overvalued or undervalued?
As of November 6, 2025, Kothari Ferment. is considered overvalued with a PE ratio of -52.52 and an EV to EBITDA of 11.14, despite trading at a discount compared to peers like Hindustan Unilever and Nestle India, while its stock has underperformed the Sensex with a year-to-date return of -34.17%.
Is Kothari Ferment. overvalued or undervalued?
As of October 27, 2025, Kothari Ferment. is considered very attractive and undervalued due to its negative PE ratio of -51.79 and favorable valuation metrics compared to peers, despite a year-to-date stock return of -35.09%.
Is Kothari Ferment. overvalued or undervalued?
As of October 17, 2025, Kothari Ferment. is considered overvalued with a negative PE ratio of -54.22 and a ROE of -2.49%, contrasting unfavorably with peers like Hindustan Unilever and Nestle India, despite a recent short-term stock outperformance against the Sensex.
{{list.post_title}}
{{list.post_excerpt}}
{{list.post_title}}
{{list.post_excerpt}}
